Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.40 |
| ▸ | PTPN2 | P17706 | 4/20 | 0.40 |
| ▸ | PTPRF | P10586 | 1/20 | 0.40 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.39 |
| ▸ | HTR3B | O95264 | 1/20 | 0.39 |
| ▸ | HTR3A | P46098 | 1/20 | 0.39 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.39 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.39 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.39 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.39 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.38 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10092123 | 0.86 | PTPN1 (0.38) | CHRNA7PTPN1PTPN2PTPRFPTPN6 | |
| SCHEMBL10092005 | 0.79 | CHRNA7 (0.48) | CHRNA7MEN1KMT2AGAAPTPN1 | |
| SCHEMBL2302942 | 0.72 | PTPN1 (0.69) | CHRNA7MEN1KMT2AGAAPTPN1 | |
| SCHEMBL5582384 | 0.72 | CHRNA7 (0.49) | CHRNA7MEN1KMT2AGAAPTPN1 | |
| SCHEMBL2696973 | 0.72 | CHRNA7 (0.49) | CHRNA7MEN1KMT2AGAAPTPN1 | |
| SCHEMBL27598256 | 0.72 | CHRNA7 (0.49) | CHRNA7MEN1KMT2AGAAPTPN1 | |
| SCHEMBL10092009 | 0.71 | PTPN1 (0.54) | CHRNA7PTPN1PTPN2PTPRFPTPN6 | |
| SCHEMBL10092104 | 0.70 | CHRNA7 (0.38) | CHRNA7MEN1KMT2AGAAPTPN1 | |
| SCHEMBL29804712 | 0.70 | CHRNA7 (0.54) | CHRNA7MEN1KMT2AGAAPTPN1 | |
| SCHEMBL28339381 | 0.69 | CHRNA7 (0.56) | CHRNA7MEN1KMT2AGAAPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120019938-A1 | CURABLE RESIN COMPOSITION FOR CEMENTED LENS, IMAGING LENS, AND METHOD FOR MANUFACTURING IMAGING LENS | FUJIFILM CORPORATION (JP) | 2012-01-26 | — | — | US | disclosed |
| US-20120019938-A1 | CURABLE RESIN COMPOSITION FOR CEMENTED LENS, IMAGING LENS, AND METHOD FOR MANUFACTURING IMAGING LENS | FUJIFILM CORPORATION (JP) | 2012-01-26 | — | — | US | disclosed |
| EP-2065890-B1 | Optical recording composition and holographic recording medium | FUJIFILM CORP (JP) | 2012-01-25 | — | — | EP | disclosed |
| US-20100241225-A1 | CURABLE RESIN COMPOSITION FOR INTRAOCULAR LENS, INTRACULAR LENS MATERIAL AND INTRACULAR LENS | FUJIFILM CORPORATION (JP) | 2010-09-23 | — | — | US | disclosed |
| US-20100241225-A1 | CURABLE RESIN COMPOSITION FOR INTRAOCULAR LENS, INTRACULAR LENS MATERIAL AND INTRACULAR LENS | FUJIFILM CORPORATION (JP) | 2010-09-23 | — | — | US | disclosed |
| US-20090142671-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-06-04 | — | — | US | disclosed |
| US-20090142671-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2009-06-04 | — | — | US | disclosed |
| EP-2065890-A2 | Optical recording composition and holographic recording medium | FUJIFILM Corporation (JP) | 2009-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090142671-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | CACNA1S, CACNA1E, CRY1 | CHRNA7 406/4885MEN1 1298/4885KMT2A 1072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.